🚀 VC round data is live in beta, check it out!
Envista Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Envista Holdings and similar public comparables like APT Medical, Lepu Medical Technology, Ypsomed, Canon Marketing Japan and more.
Envista Holdings Overview
About Envista Holdings
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Founded
2018
HQ
Employees
12.0K
Website
Financials (LTM)
EV
$5B
Envista Holdings Financials
Envista Holdings reported last 12-month revenue of $3B and EBITDA of $380M.
In the same LTM period, Envista Holdings generated $2B in gross profit, $380M in EBITDA, and $210M in net income.
Revenue (LTM)
Envista Holdings P&L
In the most recent fiscal year, Envista Holdings reported revenue of $3B and EBITDA of $372M.
Envista Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $380M | XXX | $372M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $210M | XXX | $202M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | — | — | $237M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Envista Holdings Stock Performance
Envista Holdings has current market cap of $5B, and enterprise value of $5B.
Market Cap Evolution
Envista Holdings' stock price is $29.44.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $5B | 0.0% | XXX | XXX | XXX | $1.23 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEnvista Holdings Valuation Multiples
Envista Holdings trades at 1.9x EV/Revenue multiple, and 13.7x EV/EBITDA.
EV / Revenue (LTM)
Envista Holdings Financial Valuation Multiples
As of March 30, 2026, Envista Holdings has market cap of $5B and EV of $5B.
Equity research analysts estimate Envista Holdings' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Envista Holdings has a P/E ratio of 23.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 13.7x | XXX | 14.0x | XXX | XXX | XXX |
| EV/EBIT | 15.5x | XXX | 15.9x | XXX | XXX | XXX |
| EV/Gross Profit | 3.4x | XXX | 3.5x | XXX | XXX | XXX |
| P/E | 23.0x | XXX | 23.9x | XXX | XXX | XXX |
| EV/FCF | 21.6x | XXX | 22.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Envista Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Envista Holdings Margins & Growth Rates
Envista Holdings' revenue in the last 12 month grew by 4%.
Envista Holdings' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Envista Holdings' rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Envista Holdings' rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Envista Holdings Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 46% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Envista Holdings Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| APT Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Lepu Medical Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| Ypsomed | XXX | XXX | XXX | XXX | XXX | XXX |
| Canon Marketing Japan | XXX | XXX | XXX | XXX | XXX | XXX |
| Novanta | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Envista Holdings M&A Activity
Envista Holdings acquired XXX companies to date.
Last acquisition by Envista Holdings was on XXXXXXXX, XXXXX. Envista Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Envista Holdings
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEnvista Holdings Investment Activity
Envista Holdings invested in XXX companies to date.
Envista Holdings made its latest investment on XXXXXXXX, XXXXX. Envista Holdings invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Envista Holdings
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Envista Holdings
| When was Envista Holdings founded? | Envista Holdings was founded in 2018. |
| Where is Envista Holdings headquartered? | Envista Holdings is headquartered in United States. |
| How many employees does Envista Holdings have? | As of today, Envista Holdings has over 12K employees. |
| Who is the CEO of Envista Holdings? | Envista Holdings' CEO is Paul A. Keel. |
| Is Envista Holdings publicly listed? | Yes, Envista Holdings is a public company listed on NYSE. |
| What is the stock symbol of Envista Holdings? | Envista Holdings trades under NVST ticker. |
| When did Envista Holdings go public? | Envista Holdings went public in 2019. |
| Who are competitors of Envista Holdings? | Envista Holdings main competitors are APT Medical, Lepu Medical Technology, Ypsomed, Canon Marketing Japan. |
| What is the current market cap of Envista Holdings? | Envista Holdings' current market cap is $5B. |
| What is the current revenue of Envista Holdings? | Envista Holdings' last 12 months revenue is $3B. |
| What is the current revenue growth of Envista Holdings? | Envista Holdings revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Envista Holdings? | Current revenue multiple of Envista Holdings is 1.9x. |
| Is Envista Holdings profitable? | Yes, Envista Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Envista Holdings? | Envista Holdings' last 12 months EBITDA is $380M. |
| What is Envista Holdings' EBITDA margin? | Envista Holdings' last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Envista Holdings? | Current EBITDA multiple of Envista Holdings is 13.7x. |
| What is the current FCF of Envista Holdings? | Envista Holdings' last 12 months FCF is $241M. |
| What is Envista Holdings' FCF margin? | Envista Holdings' last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Envista Holdings? | Current FCF multiple of Envista Holdings is 21.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.